We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 13, 2020

Clinical Utility of AQP4-IgG Titers and Measures of Complement-Mediated Cell Killing in Neuromyelitis Optica Spectrum Disorder

Neurology(R) neuroimmunology & neuroinflammation

 

Additional Info

Disclosure statements are available on the authors' profiles:

Neurology(R) neuroimmunology & neuroinflammation
Clinical Utility of AQP4-IgG Titers and Measures of Complement-Mediated Cell Killing in NMOSD
Neurol Neuroimmunol Neuroinflamm 2020 Jul 01;7(4)e727, J Jitprapaikulsan, JP Fryer, M Majed, CY Smith, SM Jenkins, P Cabre, SR Hinson, BG Weinshenker, J Mandrekar, JJ Chen, CF Lucchinetti, Y Jiao, J Segan, JE Schmeling, J Mills, EP Flanagan, A McKeon, SJ Pittock

Further Reading